Back to top

INSYS Therapeutics (INSY) in Focus: Stock Gains 11.2%

Read MoreHide Full Article

INSYS Therapeutics, Inc. (INSY - Free Report) was a big mover last session, as the company saw its shares rise by more than 11% on the day. The move came on solid volume too, as far more shares changed hands than in a normal session. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $33.12 to $37.20 in the past one-month time frame.

The company has seen two positive estimate revisions in the past two months and its earnings consensus has moved higher over the time frame, suggesting that more solid trading could be ahead for INSY. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

INSY currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Some other med product stocks worth considering include Boston Scientific Corporation (BSX - Free Report) , Hill-Rom Holdings, Inc. (HRC - Free Report) and diaDexus, Inc. . All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Boston Scientific Corporation (BSX) - free report >>

Hill-Rom Holdings, Inc. (HRC) - free report >>

Insys Therapeutics, Inc. (INSY) - free report >>

More from Zacks Analyst Blog

You May Like